Advertisement
AHIP 2018 discussion dominated by social determinants of health

AHIP 2018 discussion dominated by social determinants of health

By Shelby Livingston  |  June 22, 2018

AHIP's focus on issues like food, housing and transportation—factors experts say have a profound impact on a patient's health—showed insurers are beginning to pay attention to what happens outside of the hospital, even if returns are still hard to measure.

Health system-led drug company garners strong provider support

Health system-led drug company garners strong provider support

By Alex Kacik  |  May 24, 2018

Eighty percent of nearly 750 providers, payers and pharmaceutical companies polled said they are optimistic that the new health system-led generic-drug company will change the status quo, and 90% said they would buy drugs from it, according to a new survey.

Intermountain Healthcare outsourcing 98 more jobs

Intermountain Healthcare outsourcing 98 more jobs

By Tara Bannow  |  March 28, 2018

Intermountain Healthcare announced it will outsource 98 information technology jobs to DXC Technology, which will continue their employment for at least one year.

Intermountain latest provider to outsource revenue-cycle management

Intermountain latest provider to outsource revenue-cycle management

By Alex Kacik  |  January 27, 2018

Salt Lake City-based Intermountain Healthcare will outsource 2,300 nonclinical employees to revenue-cycle management company R1 RCM, a move that is expected to save the integrated health system $70 million over the next three years.

Intermountain to outsource 2,300 employees

Intermountain to outsource 2,300 employees

By Alex Kacik  |  January 24, 2018

Salt Lake City-based Intermountain Healthcare will outsource 2,300 non clinical employees to revenue cycle management company R1 RCM, a move that is expected to save the integrated health system $70 million over the next three years.

Providers' solution for high drug prices: Make them ourselves

Providers' solution for high drug prices: Make them ourselves

By Alex Kacik and Tara Bannow  |  January 20, 2018

The new health system-led generic-drug company sent a shockwave through the healthcare industry, but experts warned that it would take plenty of time and capital to ultimately lower drug prices and mitigate shortages.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print